EE464 The Cost-Effectiveness of Subcutaneous Semaglutide 2.4MG Injection in the Management of Obesity in Canada Using the Core Obesity Model
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.712
https://www.valueinhealthjournal.com/article/S1098-3015(22)00913-5/fulltext
Title :
EE464 The Cost-Effectiveness of Subcutaneous Semaglutide 2.4MG Injection in the Management of Obesity in Canada Using the Core Obesity Model
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00913-5&doi=10.1016/j.jval.2022.04.712
First page :
Section Title :
Open access? :
No
Section Order :
10641